Who
Neil Herskowitz
Director
Company insider
Files Form 4 as: Director, Journey Medical; Director, Mustang Bio; Director, Checkpoint Therapeutics; Director, Avenue Therapeutics; Director, National Holdings; Director, CB Pharma Acquisition; Director, TG Therapeutics; Director, CytRx Oncology.
In numbers
- Trades disclosed
- 105
- Buys
- 27
- Sells
- 3
- Bought
- $453K
- Sold
- $283
- Companies
- 9
- Companies where not an officer
- 9
- First trade
- 26 Aug 2005
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 25 Jun 2026filed 26 Jun 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 25 Jun 2026filed 26 Jun 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 30 Dec 2025filed 30 Dec 2025 | MBIO Mustang BioBiotechnology | SEC FORM 4 Sold | $237247 at $0.96 | filing |
| 5 Aug 2025filed 7 Aug 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 25 Jun 2025filed 7 Jul 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —7,173 at $0.00 | filing |
| 30 May 2025filed 30 May 2025 | Checkpoint Therapeutics | SEC FORM 4 Code U | —147,007 | filing |
| 28 May 2025filed 30 May 2025 | Checkpoint Therapeutics | SEC FORM 4 Code A | —12,195 at $0.00 | filing |
| 13 Dec 2024filed 17 Dec 2024 | Checkpoint Therapeutics | SEC FORM 4 Code A | —17,638 at $0.00 | filing |
| 2 Dec 2024filed 3 Dec 2024 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Sold | $4623 at $2.00 | filing |
| 23 Sep 2024filed 25 Sep 2024 | Avenue Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 8 Jul 2024filed 10 Jul 2024 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —9,728 at $0.00 | filing |
| 14 May 2024filed 16 May 2024 | Checkpoint Therapeutics | SEC FORM 4 Code A | —32,051 at $0.00 | filing |
| 14 May 2024filed 16 May 2024 | Checkpoint Therapeutics | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 21 Jul 2023filed 25 Jul 2023 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —27,472 at $0.00 | filing |
| 5 Jul 2023filed 7 Jul 2023 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —7,246 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | Avenue Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | Checkpoint Therapeutics | SEC FORM 4 Code A | —17,483 at $0.00 | filing |
| 29 Jul 2022filed 3 Apr 2023 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —71,664 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.